PEPTOK

Weight Loss Peptides

The definitive guide · 12 compounds · Updated February 2026

From FDA-approved GLP-1 agonists to emerging triple-receptor compounds, this guide covers every peptide used for weight management — with mechanisms of action, clinical evidence, safety profiles, dosing protocols, and how to find trusted sources.

12
Peptides Covered
3
FDA Approved
3
In Phase 3 Trials
22.5%
Max Weight Loss (Tirzepatide)

GLP-1 Receptor Agonists

The gold standard — FDA-approved with the strongest clinical evidence

💊

Semaglutide

GLP-1 AgonistFDA ApprovedStrong Evidence

Also known as: Ozempic, Wegovy, Rybelsus

Safety Score
9/10

How It Works

Mimics GLP-1 hormone to reduce appetite, slow gastric emptying, and improve insulin sensitivity. Acts on hypothalamic appetite centers to produce satiety.

Weight Loss
~15% body weight
Timeline
68 weeks (STEP trials)
Dosing
0.25mg → 2.4mg (titration)
Frequency
Once weekly injection

Side Effects

  • Nausea (most common, usually transient)
  • Vomiting
  • Diarrhea/Constipation
  • Abdominal pain
  • Headache
  • Injection site reactions

Best For

  • Obesity (BMI ≥30)
  • Overweight with comorbidities
  • Type 2 diabetes + weight loss
  • Long-term weight management
Key Research: STEP 1: 14.9% mean weight loss at 68 weeks vs 2.4% placebo (NEJM 2021)
💉

Liraglutide

GLP-1 AgonistFDA ApprovedStrong Evidence

Also known as: Saxenda, Victoza

Safety Score
9/10

How It Works

First GLP-1 agonist approved for weight management. Shorter-acting than semaglutide, requires daily dosing. Well-established safety profile with years of clinical use.

Weight Loss
~8% body weight
Timeline
56 weeks (SCALE trials)
Dosing
0.6mg → 3.0mg (titration)
Frequency
Daily injection

Side Effects

  • Nausea
  • Diarrhea
  • Constipation
  • Vomiting
  • Low blood sugar
  • Injection site reactions

Best For

  • Moderate weight loss goals
  • Those preferring established safety data
  • Adolescent obesity (age 12+)
  • Step-down from semaglutide
Key Research: SCALE Obesity: 8.0% mean weight loss at 3.0mg daily over 56 weeks (NEJM 2015)
🎯

Dual & Triple Agonists

Next-gen multi-receptor targeting for enhanced results

🎯

Tirzepatide

Dual GLP-1/GIP AgonistFDA ApprovedStrong Evidence

Also known as: Mounjaro, Zepbound

Safety Score
9/10

How It Works

First-in-class dual incretin agonist targeting both GLP-1 and GIP receptors. GIP receptor activation enhances fat oxidation and energy expenditure beyond GLP-1 alone.

Weight Loss
~22.5% body weight
Timeline
72 weeks (SURMOUNT-1)
Dosing
2.5mg → 15mg (titration)
Frequency
Once weekly injection

Side Effects

  • Nausea
  • Diarrhea
  • Decreased appetite
  • Vomiting
  • Constipation
  • Injection site reactions

Best For

  • Maximum weight loss potential
  • Obesity (BMI ≥30)
  • Type 2 diabetes + obesity
  • Metabolic syndrome
Key Research: SURMOUNT-1: 22.5% mean weight loss at 15mg dose over 72 weeks (NEJM 2022)

Growth Hormone Peptides

Body recomposition through natural GH stimulation

🔥

Tesamorelin

GHRH AnalogFDA Approved (lipodystrophy)Strong Evidence

Also known as: Egrifta

Safety Score
8/10

How It Works

Stimulates pituitary to release growth hormone naturally. Specifically targets visceral (belly) fat reduction while preserving muscle mass. Does not suppress natural GH production.

Weight Loss
~15-20% visceral fat reduction
Timeline
26 weeks
Dosing
2mg daily
Frequency
Daily subcutaneous injection

Side Effects

  • Injection site reactions
  • Joint pain
  • Muscle pain
  • Swelling of extremities
  • Tingling/numbness

Best For

  • Visceral fat specifically
  • HIV-associated lipodystrophy
  • Stubborn belly fat
  • Those wanting GH benefits without exogenous GH
Key Research: Reduced visceral adipose tissue by 15-18% over 26 weeks in HIV lipodystrophy trials (NEJM 2010)

CJC-1295 + Ipamorelin

GH Secretagogue StackResearch OnlyModerate Evidence

Also known as: CJC-1295/DAC, Modified GRF 1-29

Safety Score
6/10

How It Works

Synergistic stack: CJC-1295 stimulates GH release via GHRH pathway while ipamorelin triggers GH pulse via ghrelin receptor. Together they amplify natural GH production for fat loss and body recomposition.

Weight Loss
Body recomposition (fat loss + muscle gain)
Timeline
8-12 weeks typical
Dosing
CJC-1295: 100mcg + Ipamorelin: 100-300mcg
Frequency
2-3x daily (before bed ideal)

Side Effects

  • Water retention (transient)
  • Tingling/numbness
  • Increased hunger
  • Headache
  • Flushing

Best For

  • Body recomposition goals
  • Those wanting GH benefits
  • Anti-aging + fat loss combo
  • Athletes and fitness enthusiasts
Key Research: Limited clinical data — primarily used in research settings. GH release patterns studied in Phase 2 trials.
🧬

Metabolic & Novel Peptides

Unique mechanisms — NNMT inhibition, mitochondrial, gut-brain

🧬

AOD 9604

GH FragmentResearch OnlyLimited Evidence

Also known as: Anti-Obesity Drug Fragment, hGH Fragment 176-191

Safety Score
5/10

How It Works

Isolated fat-burning fragment of growth hormone. Stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat formation) without the growth-promoting or diabetogenic effects of full GH.

Weight Loss
~2-3 kg over 12 weeks (clinical trials)
Timeline
12 weeks
Dosing
250-500mcg daily
Frequency
Daily subcutaneous injection (fasted, morning)

Side Effects

  • Injection site reactions
  • Headache
  • Generally well-tolerated in trials
  • Limited long-term safety data

Best For

  • Targeted fat loss without GH side effects
  • Those concerned about GH-related risks
  • Complement to diet/exercise
  • Research applications
Key Research: Metabolic Pharmaceuticals Phase 2b: Modest but significant fat loss vs placebo over 12 weeks (2004)
🔬

MOTS-c

Mitochondrial PeptideResearch OnlyPreclinical Only

Also known as: Mitochondrial ORF of the 12S rRNA Type-c

Safety Score
4/10

How It Works

Encoded within mitochondrial DNA. Activates AMPK pathway (the "exercise switch"), improves insulin sensitivity, enhances fatty acid oxidation, and mimics some metabolic effects of exercise.

Weight Loss
Prevented diet-induced obesity in animal models
Timeline
Limited human data
Dosing
5-10mg weekly (research protocols)
Frequency
Weekly subcutaneous injection

Side Effects

  • Very limited human safety data
  • Injection site reactions reported
  • Theoretical: metabolic stress

Best For

  • Metabolic dysfunction research
  • Insulin resistance
  • Exercise mimetic applications
  • Early adopters comfortable with limited data
Key Research: Lee et al. 2015 (Cell Metabolism): Prevented age- and diet-dependent insulin resistance in mice
💊

5-Amino-1MQ

NNMT InhibitorResearch OnlyPreclinical Only

Also known as: 5-amino-1-methylquinolinium

Safety Score
4/10

How It Works

Inhibits NNMT enzyme which is overexpressed in fat tissue. Blocking NNMT increases cellular energy expenditure, activates fat cell metabolism, and reduces lipid accumulation. Oral availability is a major advantage.

Weight Loss
Significant fat reduction in animal models (~30% body fat decrease)
Timeline
10 days showed results in mice
Dosing
50-100mg daily (research protocols)
Frequency
Daily oral capsule

Side Effects

  • Very limited human safety data
  • Theoretical: liver/kidney effects
  • Nausea reported anecdotally

Best For

  • Those preferring oral peptides (no injections)
  • Metabolic research
  • NNMT-related metabolic dysfunction
  • Experimental/early-adopter profile
Key Research: Neelakantan et al. 2018 (Biochemical Pharmacology): 30% reduction in body fat in HFD mice within 10 days
🛡️

BPC-157

Cytoprotective PeptideResearch OnlyLimited Evidence

Also known as: Body Protection Compound-157, Pentadecapeptide

Safety Score
6/10

How It Works

Derived from human gastric juice protein. Primarily known for tissue healing, but emerging research shows effects on gut microbiome, gut-brain axis signaling, and metabolic regulation. May enhance weight loss indirectly through improved gut health and nutrient partitioning.

Weight Loss
Indirect — supports metabolic health & gut function
Timeline
4-12 weeks for gut health effects
Dosing
250-500mcg daily
Frequency
1-2x daily subcutaneous or oral

Side Effects

  • Generally well-tolerated
  • Nausea (uncommon)
  • Dizziness (rare)
  • Limited long-term human data

Best For

  • Gut health optimization
  • GLP-1 side effect management
  • Complementary to primary weight loss peptides
  • Tissue healing + metabolic support
Key Research: Extensive animal data on tissue repair; metabolic effects studied in rodent models (multiple publications)
🚀

Pipeline & Emerging

In clinical trials — not yet commercially available

🚀

Retatrutide

Triple Agonist (GLP-1/GIP/Glucagon)Phase 3 Clinical TrialsModerate Evidence

Also known as: LY3437943, Triple G (GGG agonist)

Safety Score
7/10

How It Works

First triple agonist targeting GLP-1, GIP, AND glucagon receptors. Glucagon component adds thermogenesis and hepatic fat reduction. In Phase 3 trials — potentially the most effective weight loss peptide ever studied.

Weight Loss
~24.2% body weight (highest dose)
Timeline
48 weeks (Phase 2)
Dosing
1mg → 12mg (titration)
Frequency
Once weekly injection

Side Effects

  • Nausea
  • Diarrhea
  • Vomiting
  • Constipation
  • Similar GI profile to GLP-1s

Best For

  • Maximum possible weight loss
  • Those monitoring pipeline compounds
  • Metabolic syndrome research
  • Not yet available commercially
Key Research: Phase 2: 24.2% weight loss at 12mg over 48 weeks — exceeding all existing compounds (NEJM 2023)
🔮

Survodutide

Dual GLP-1/Glucagon AgonistPhase 3 Clinical TrialsModerate Evidence

Also known as: BI 456906

Safety Score
6/10

How It Works

Unlike tirzepatide (GLP-1/GIP), survodutide pairs GLP-1 with glucagon receptor activation. Glucagon component increases energy expenditure and reduces liver fat — promising for NASH/MAFLD.

Weight Loss
~18.7% body weight
Timeline
46 weeks (Phase 2)
Dosing
Titration to 4.8mg or 6.0mg
Frequency
Once weekly injection

Side Effects

  • Nausea
  • Diarrhea
  • Vomiting
  • Similar to GLP-1 class

Best For

  • Liver fat reduction + weight loss
  • NASH/MAFLD research
  • Those monitoring pipeline
  • Not yet available commercially
Key Research: Phase 2: 18.7% weight loss + significant liver fat reduction over 46 weeks (Lancet 2024)
🧠

Tesofensine

Triple Monoamine Reuptake InhibitorPhase 3 (Outside US)Moderate Evidence

Also known as: NS2330

Safety Score
5/10

How It Works

Originally developed for Parkinson's/Alzheimer's. Works centrally to reduce appetite and increase thermogenesis via triple neurotransmitter reuptake inhibition. Different mechanism from all other weight loss peptides.

Weight Loss
~10-13% body weight
Timeline
24 weeks
Dosing
0.25-0.5mg daily
Frequency
Daily oral capsule

Side Effects

  • Dry mouth
  • Insomnia
  • Constipation
  • Increased heart rate
  • Mood changes
  • Elevated blood pressure

Best For

  • Those who cannot tolerate GLP-1s
  • Oral preference (no injections)
  • Appetite-driven overeating
  • Research applications
Key Research: TIPO-1 Phase 2: 10.6% weight loss at 0.5mg over 24 weeks (Lancet 2008)

📊 Head-to-Head Comparison

How the top weight loss peptides stack up against each other

PeptideMechanismWeight LossSafetyStatusFrequency
💊 Semaglutide
Ozempic
GLP-1 Receptor Agonist~15% body weight9/10FDA ApprovedOnce weekly injection
🎯 Tirzepatide
Mounjaro
Dual GLP-1/GIP Receptor Agonist~22.5% body weight9/10FDA ApprovedOnce weekly injection
💉 Liraglutide
Saxenda
GLP-1 Receptor Agonist~8% body weight9/10FDA ApprovedDaily injection
🚀 Retatrutide
LY3437943
Triple Incretin Receptor Agonist~24.2% body weight (highest dose)7/10Phase 3 Clinical TrialsOnce weekly injection
🔮 Survodutide
BI 456906
Dual GLP-1/Glucagon Receptor Agonist~18.7% body weight6/10Phase 3 Clinical TrialsOnce weekly injection
🧠 Tesofensine
NS2330
Serotonin/Norepinephrine/Dopamine Reuptake Inhibitor~10-13% body weight5/10Phase 3 (Outside US)Daily oral capsule

🛒 How People Buy Peptides

Understanding the different paths to accessing weight loss peptides

Prescription (Telehealth)

FDA-approved brand-name peptides (Wegovy, Mounjaro, Saxenda) via telehealth consultations or your doctor. Insurance may cover.

FDA regulated
Medical oversight
Insurance possible

Compounding Pharmacies

Custom-compounded versions of approved peptides. Often more affordable. Still requires prescription but typically through affiliated providers.

Prescription required
More affordable
Quality varies

Research Chemical Vendors

Research-use peptides from specialty vendors. No prescription needed. Sold "for research only." This is where most non-FDA-approved peptides are sourced.

No prescription
Widest selection
Verify 3rd-party testing

What to Look for When Choosing a Vendor

Third-Party COAs

Certificates of Analysis from independent labs verifying purity (≥98%) and identity

HPLC/Mass Spec Testing

High-performance liquid chromatography confirms peptide identity and purity

Transparent Business

Real business address, responsive customer service, clear return policy

Community Reputation

Verified reviews, community forum presence, established track record (1+ years)

Find Verified Peptide Vendors

We review and verify peptide vendors based on third-party testing, pricing transparency, customer reviews, and shipping reliability.

View All Verified Vendors

❓ Frequently Asked Questions

What is the most effective peptide for weight loss?

Based on clinical trial data, tirzepatide (Mounjaro/Zepbound) produces the highest weight loss at approximately 22.5% of body weight over 72 weeks. Retatrutide, still in Phase 3 trials, has shown up to 24.2% in Phase 2 data. Among widely available options, semaglutide (Wegovy) at ~15% body weight loss remains the most prescribed.

Are weight loss peptides safe?

FDA-approved GLP-1 agonists (semaglutide, tirzepatide, liraglutide) have extensive safety data from trials involving tens of thousands of participants. The most common side effects are gastrointestinal (nausea, usually temporary). Research-only peptides like AOD 9604 and MOTS-c have significantly less safety data. Always consult a healthcare provider before starting any peptide protocol.

What is the difference between semaglutide and tirzepatide?

Semaglutide targets GLP-1 receptors only. Tirzepatide targets both GLP-1 and GIP receptors (dual agonist), which provides additional metabolic benefits. Clinical trials show tirzepatide produces roughly 50% greater weight loss than semaglutide. Both are given as weekly injections.

Can I buy peptides without a prescription?

FDA-approved peptides (semaglutide, tirzepatide, liraglutide) require a prescription. Research peptides (AOD 9604, MOTS-c, CJC-1295, 5-Amino-1MQ) are sold by research chemical vendors without a prescription, labeled "for research purposes only." Compounded versions of approved peptides require a prescription through affiliated providers.

How do I know if a peptide vendor is trustworthy?

Look for: (1) Third-party Certificates of Analysis (COAs) from independent labs, (2) HPLC and mass spectrometry testing results, (3) Transparent business information and customer service, (4) Positive community reviews on independent forums. We review and verify vendors on our Vendors page.

Related Research

However: Cognitive Benefits & Protocols (2026)

What Is "However"? “However” is a word we use a lot. It's a transition word. Transition words help connect ideas in sentences and paragraphs. "However" usually shows a contrast or disagreement between two things. It tells the reader that what's coming next will be different from what came before. T...

Read

"Where do I go after Peptide Sciences?" (2026)

What Is "Where Do I Go After Peptide Sciences?" Peptide Sciences is a company that sells peptides. Peptides are short chains of amino acids. Amino acids are the building blocks of proteins. Some people use peptides for different reasons, like trying to improve their health or fitness. This article i...

Read

Peptide Stacks for Longevity: Combining BPC-157, GHK-Cu, and Epitalon

Longevity is rarely a single-molecule game. We explore how BPC-157, GHK-Cu, and Epitalon work synergistically to support cellular repair, tissue regeneration, and telomere maintenance.

Read

r/peptides & MuscleChemistry:: Research Guide & Dosing (2026)

What Is r/peptides & MuscleChemistry? r/peptides and MuscleChemistry are online communities. They are found on platforms like Reddit and dedicated forums. People go there to talk about peptides and other substances. These substances are often used to try and improve athletic performance or body comp...

Read

Retatrutide vs. Tirzepatide: The Next Generation of Weight Loss Peptides in 2026

As weight loss peptide therapy evolves, Retatrutide (the "triple agonist") is challenging Tirzepatide for the crown. We compare the mechanisms, weight loss results, and side effect profiles of these two powerful GLP-1 derivatives.

Read

Key compounds highlighted: — Which Is Right for You? (2026)

What Is Creatine? Creatine is a natural substance found in your body. It's also a popular supplement, often used by athletes and bodybuilders. Your body makes creatine, and you also get it from eating meat and fish. Creatine helps your muscles make energy, especially during high-intensity exercise....

Read

Explore Other Mechanisms

Medical Disclaimer

This content is for informational and educational purposes only. It is not intended as medical advice, diagnosis, or treatment. Peptides discussed here range from FDA-approved medications to research-only compounds. Always consult with a qualified healthcare provider before starting any peptide protocol. Research-only peptides are not approved for human consumption. Peptok does not sell peptides.